IL105276A - (S)-a-PHENYL- 2-PYRIDINEETHANAMINE, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT - Google Patents

(S)-a-PHENYL- 2-PYRIDINEETHANAMINE, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Info

Publication number
IL105276A
IL105276A IL105276A IL10527693A IL105276A IL 105276 A IL105276 A IL 105276A IL 105276 A IL105276 A IL 105276A IL 10527693 A IL10527693 A IL 10527693A IL 105276 A IL105276 A IL 105276A
Authority
IL
Israel
Prior art keywords
pyridineethanamine
phenyl
production
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL105276A
Other languages
English (en)
Other versions
IL105276A0 (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929207339A external-priority patent/GB9207339D0/en
Priority claimed from GB929208290A external-priority patent/GB9208290D0/en
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL105276A0 publication Critical patent/IL105276A0/xx
Publication of IL105276A publication Critical patent/IL105276A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IL105276A 1992-04-03 1993-04-02 (S)-a-PHENYL- 2-PYRIDINEETHANAMINE, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT IL105276A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929207339A GB9207339D0 (en) 1992-04-03 1992-04-03 Pharmaceutical compound
GB929208290A GB9208290D0 (en) 1992-04-15 1992-04-15 Pharmaceutical compound having neuroprotective properties

Publications (2)

Publication Number Publication Date
IL105276A0 IL105276A0 (en) 1993-08-18
IL105276A true IL105276A (en) 1997-06-10

Family

ID=26300643

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105276A IL105276A (en) 1992-04-03 1993-04-02 (S)-a-PHENYL- 2-PYRIDINEETHANAMINE, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Country Status (29)

Country Link
EP (1) EP0633879B1 (ru)
JP (2) JP3120810B2 (ru)
KR (1) KR100259567B1 (ru)
CN (1) CN1044367C (ru)
AT (1) ATE163925T1 (ru)
AU (2) AU3897693A (ru)
CA (1) CA2133427C (ru)
CZ (1) CZ288519B6 (ru)
DE (1) DE69317411T2 (ru)
DK (1) DK0633879T3 (ru)
DZ (1) DZ1677A1 (ru)
ES (1) ES2115055T3 (ru)
FI (1) FI105025B (ru)
HK (1) HK1009331A1 (ru)
HU (1) HU211529A9 (ru)
IL (1) IL105276A (ru)
MA (1) MA22866A1 (ru)
MX (1) MX9301935A (ru)
MY (1) MY110149A (ru)
NO (1) NO302170B1 (ru)
NZ (1) NZ251384A (ru)
PL (1) PL180014B1 (ru)
RU (1) RU2128650C1 (ru)
SG (1) SG47948A1 (ru)
SK (1) SK281258B6 (ru)
TW (1) TW282455B (ru)
UA (1) UA29437C2 (ru)
WO (1) WO1993020052A1 (ru)
ZA (1) ZA932415B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320273D0 (en) * 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
EP0648489A1 (en) * 1988-08-12 1995-04-19 Fisons Corporation Arylalkylamides having neuroprotective properties
ZA942140B (en) * 1993-04-01 1994-10-03 Fisons Corp Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
SE9901077D0 (sv) * 1999-03-23 1999-03-23 Astra Ab Novel use
SE9901237D0 (sv) * 1999-04-06 1999-04-06 Astra Ab Novel use
SE9901340D0 (sv) 1999-04-15 1999-04-15 Astra Pharma Prod Novel process
WO2007017652A2 (en) * 2005-08-10 2007-02-15 Astrazeneca Ab Arylakylamines for the treatment of cancer
SG171928A1 (en) 2008-12-24 2011-07-28 Astrazeneca Ab Ethanamine compounds and their use for treating depression
JP2015501652A (ja) 2011-12-14 2015-01-19 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ Ｇａｂｒ−ａ２診断
PT3066091T (pt) 2013-11-05 2019-07-11 Astrazeneca Ab Pro-farmacos de antagonista de nmda
US20230190719A1 (en) * 2020-06-23 2023-06-22 Biohaven Therapeutics Ltd. Topical formulations of (1s)-1-phenyl-2-pyridin-2-ylethanamine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0648489A1 (en) * 1988-08-12 1995-04-19 Fisons Corporation Arylalkylamides having neuroprotective properties

Also Published As

Publication number Publication date
EP0633879B1 (en) 1998-03-11
TW282455B (ru) 1996-08-01
AU3897693A (en) 1993-11-08
DK0633879T3 (da) 1998-09-28
SG47948A1 (en) 1998-04-17
EP0633879A1 (en) 1995-01-18
CN1081669A (zh) 1994-02-09
NO302170B1 (no) 1998-02-02
NZ251384A (en) 1996-10-28
SK117794A3 (en) 1995-05-10
MA22866A1 (fr) 1993-12-31
CZ240994A3 (en) 1995-12-13
CA2133427C (en) 2003-06-10
MX9301935A (es) 1994-08-31
ZA932415B (en) 1993-10-22
SK281258B6 (sk) 2001-01-18
DE69317411T2 (de) 1998-07-30
CN1044367C (zh) 1999-07-28
NO943645L (no) 1994-11-16
IL105276A0 (en) 1993-08-18
HU211529A9 (en) 1995-11-28
NO943645D0 (no) 1994-09-30
PL180014B1 (pl) 2000-11-30
CA2133427A1 (en) 1993-10-14
FI944546A (fi) 1994-09-30
FI944546A0 (fi) 1994-09-30
AU7545696A (en) 1997-02-13
RU2128650C1 (ru) 1999-04-10
JP2000319259A (ja) 2000-11-21
CZ288519B6 (cs) 2001-07-11
DE69317411D1 (de) 1998-04-16
AU705419B2 (en) 1999-05-20
JPH07505385A (ja) 1995-06-15
WO1993020052A1 (en) 1993-10-14
HK1009331A1 (en) 1999-05-28
UA29437C2 (ru) 2000-11-15
DZ1677A1 (fr) 2002-02-17
MY110149A (en) 1998-02-28
KR100259567B1 (ko) 2000-07-01
JP3120810B2 (ja) 2000-12-25
FI105025B (fi) 2000-05-31
ES2115055T3 (es) 1998-06-16
ATE163925T1 (de) 1998-03-15
RU94042465A (ru) 1996-07-20

Similar Documents

Publication Publication Date Title
GR3036253T3 (en) Cyclopropyl alkanoic acid derivatives
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
MY115662A (en) Novel compounds with analgesic effect
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
AU2337197A (en) Cinnamic acid derivatives and their use as integrin antagonists
UA34428C2 (ru) Замещенные фенилимидазолидины, способ их получения, фармацевтическая композиция, промежуточные соединения
NZ244021A (en) Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
GR3023936T3 (en) Heterocyclic alkylamides, process for their preparation and pharmaceutical compositions containing them
UA27749C2 (ru) Замещенные циклопропиламино-1,3, 5-триазины, их оптические изомеры, рацемические смеси или их соли присоединения нетоксичных фармацевтически приемлемых кислот, имеющих фармакологическую активность, способ их получения
EP0807633A3 (en) Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
UA39101C2 (ru) ПРОИЗВОДНЫЕ 11b-БЕНЗАЛЬДОКСИМ-ЭСТРА-4,9-ДИЕНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ С АНТИПРОГЕСТИНОВОЙ АКТИВНОСТЬЮ
IL91949A (en) Dispersible formulation containing the free acid form of diclofenac
UA29435C2 (ru) ПРОИЗВОДНЫЕ 3 <font face="Symbol">b</font>-АЛКЕНИЛПЕНАМА И ИХ ФАРМАЦЕВТИЧЕСКИ СОВМЕСТИМЫЕ СОЛИ
IL105276A (en) (S)-a-PHENYL- 2-PYRIDINEETHANAMINE, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
HU9303749D0 (en) 2,4-substituted 5-(n-substituted-sulfamoyl)-benzoyl-guanidines, process for producing them, their use as medicine or diagnosticum and pharmaceutical compositions containing them
IL112098A0 (en) Sulfamate derivatives and pharmaceutical compositions containing them
SG64906A1 (en) New bis-naphthalimides for the treatment of cancer
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
HU9303000D0 (en) Aryl-morpholine-derivatives and pharmaceutical compositions containing it and process for production thereof
HK1005454A1 (en) Pure crystalline form of refapentine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired